New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 5, 2017 – GlaxoSmithKline (GSK) announced the permanent discontinuation and market withdrawal of Potiga (ezogabine) tablets due to the limited use of the medicine.
Download PDF
Return to publications
